Permanently implantable system for detecting, diagnosing and treating congestive heart failure
Abstract
The invention provides improved apparatus and methods for treating congestive heart failure in a medical patient. The apparatus includes a pressure transducer permanently implantable within the left atrium of the patient's heart and operable to generate electrical signals indicative of fluid pressures within the patient's left atrium. The pressure transducer is connected to a flexible electrical lead, which is connected in turn to electrical circuitry, which in the preferred embodiment includes digital circuitry for processing electrical signals. The electrical circuitry processes the electrical signals from the pressure transducer and, based at least in part on those signals, generates a signal that indicates a desired therapeutic treatment for treating the patient's condition. That signal is then communicated to the patient via a patient signaling device, following which the patient administers to him or herself the prescribed therapeutic treatment indicated by the signal.
Term
Term ended
Projected expiry passed 9 January 2021, 5.7 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
43 members in 10 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 48108400 | United States of America | A |
Members43
| Document | Office | Kind | |
|---|---|---|---|
| WO0151123A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2936401A | Australia | A | |
| US6328699B1 | United States of America | B1 | |
| EP1257321A1 | European Patent Office (EPO) | A1 | |
| US2003055344A1 | United States of America | A1 | |
| US2003055345A1 | United States of America | A1 | |
| JP2003519542A | Japan | A | |
| US2004147969A1 | United States of America | A1 | |
| US2004167580A1 | United States of America | A1 | |
| AU2004251601A1 | Australia | A1 | |
| AU2004251601A2 | Australia | A2 | |
| CA2525193A1 | Canada | A1 | |
| WO2005000206A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2005000206A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US6970742B2 | United States of America | B2 | |
| US2006009810A1 | United States of America | A1 | |
| EP1622680A2 | European Patent Office (EPO) | A2 | |
| US2006079793A1 | United States of America | A1 | |
| CN1819855A | China | A | |
| US7115095B2 | United States of America | B2 | |
| US7137953B2 | United States of America | B2 | |
| US2007032831A1 | United States of America | A1 | |
| JP2007503286A | Japan | A | |
| US2007088223A1 | United States of America | A1 | |
| US2007232936A1 | United States of America | A1 | |
| US2008033498A1 | United States of America | A1 | |
| US2008039821A1 | United States of America | A1 | |
| EP1622680A4 | European Patent Office (EPO) | A4 | |
| EP1257321B1 | European Patent Office (EPO) | B1 | |
| AT401930T | Austria | T | |
| ATE401930T1This record | Austria | T1 | |
| DE60134959D1 | Germany | D1 | |
| US7483743B2 | United States of America | B2 | |
| US7590449B2 | United States of America | B2 | |
| NZ543592A | New Zealand | A | |
| US7717854B2 | United States of America | B2 | |
| JP4776132B2 | Japan | B2 | |
| US8068907B2 | United States of America | B2 | |
| US8298150B2 | United States of America | B2 | |
| US8480594B2 | United States of America | B2 | |
| US9055917B2 | United States of America | B2 | |
| CA2525193C | Canada | C | |
| US2016129260A1 | United States of America | A1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 1942315
Titles2
- German
- PERMANENT IMPLANTIERBARES SYSTEM ZUR DETEKTION, DIAGNOSE UND BEHANDLUNG VON ANGEBOREN HERZFEHLERN
- English
- PERMANENTLY IMPLANTABLE SYSTEM FOR THE DETECTION, DIAGNOSIS AND TREATMENT OF CONGENITAL HEART DEFECTS
Classification
- CPC, 6
- A61B5/0215
- A61B5/4839
- A61B5/6882
- A61B2560/0209
- A61N1/3627
- A61N1/36564
- IPC, 4
- A61B5 00
- A61B5 0215
- A61N1 362
- A61N1 365